Literature DB >> 28629699

Understanding the applicability of results from primary care trials: lessons learned from applying PRECIS-2.

Gordon Forbes1, Kirsty Loudon2, Shaun Treweek3, Stephanie J C Taylor4, Sandra Eldridge4.   

Abstract

OBJECTIVE: To compare two approaches for trial teams to apply PRECIS-2 to pragmatic trials: independent scoring and scoring following a group discussion. STUDY DESIGN AND
SETTING: We recruited multidisciplinary teams who were conducting or had conducted trials in primary care in collaboration with the Pragmatic Clinical Trials Unit, Queen Mary University of London. Each team carried out two rounds of scoring on the nine PRECIS-2 domains: first independently using an online version of PRECIS-2 and second following a discussion.
RESULTS: Seven teams took part in the study. Before the discussion, within-team agreement in scores was generally poor and not all raters were able to score all domains; agreement improved after the discussion. The PRECIS-2 wheels suggested that the trials were pragmatic, although some domains were more pragmatic than others.
CONCLUSION: PRECIS-2 can facilitate information exchange within trial teams. To apply PRECIS-2 successfully, we recommend a discussion between those with detailed understanding of what usual care is for the intervention, the trial's design including operational and technical aspects, and the PRECIS-2 domains. For some cluster-randomized trials, greater insight may be gained by plotting two PRECIS-2 wheels, one at the individual participant level and another at the cluster level.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Clinical trial methodology; Pragmatic trial; Primary care; Randomized controlled trials; Trial design

Mesh:

Year:  2017        PMID: 28629699     DOI: 10.1016/j.jclinepi.2017.06.007

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  10 in total

1.  The PRECIS-2 tool seems not to be useful to discriminate the degree of pragmatism of medicine masked trials from that of open-label trials.

Authors:  Rafael Dal-Ré
Journal:  Eur J Clin Pharmacol       Date:  2020-10-26       Impact factor: 2.953

2.  Use of the PRECIS-II instrument to categorize reports along the efficacy-effectiveness spectrum in an hepatitis C virus care continuum systematic review and meta-analysis.

Authors:  Ashly E Jordan; David C Perlman; Daniel J Smith; Jennifer R Reed; Holly Hagan
Journal:  J Clin Epidemiol       Date:  2017-11-02       Impact factor: 6.437

3.  The OaSiS trial: A hybrid type II, national cluster randomized trial to implement smoking cessation during CT screening for lung cancer.

Authors:  Kristie Long Foley; David P Miller; Kathryn Weaver; Erin L Sutfin; W Jeffrey Petty; Christina Bellinger; John Spangler; Rebecca J Stone; Donna Lawler; Whitney Davis; Emily Dressler; Glenn Lesser; Caroline Chiles
Journal:  Contemp Clin Trials       Date:  2020-02-20       Impact factor: 2.226

4.  Framing the conversation: use of PRECIS-2 ratings to advance understanding of pragmatic trial design domains.

Authors:  Paula Darby Lipman; Kirsty Loudon; Leanora Dluzak; Rachael Moloney; Donna Messner; Catherine M Stoney
Journal:  Trials       Date:  2017-11-10       Impact factor: 2.279

5.  A dynamic application of PRECIS-2 to evaluate implementation in a pragmatic, cluster randomized clinical trial in two nursing home systems.

Authors:  Jennifer A Palmer; Vincent Mor; Angelo E Volandes; Ellen McCreedy; Lacey Loomer; Phoebe Carter; Faye Dvorchak; Susan L Mitchell
Journal:  Trials       Date:  2018-08-22       Impact factor: 2.279

6.  Evaluating the effectiveness and cost-effectiveness of the Smoking Treatment Optimisation in Pharmacies (STOP) intervention: protocol for a cluster randomised controlled trial.

Authors:  Ratna Sohanpal; Sandra Jumbe; Wai-Yee James; Liz Steed; Tammy Yau; Carol Rivas; Vichithranie Madurasinghe; Colin Houlihan; Vlad Berdunisov; Matthew Taylor; Stephanie J C Taylor; Chris Griffiths; Sandra Eldridge; Robert Walton
Journal:  Trials       Date:  2019-06-10       Impact factor: 2.279

7.  Pragmatic Trials in Genomic Medicine: The Integrating Pharmacogenetics In Clinical Care (I-PICC) Study.

Authors:  Charles A Brunette; Stephen J Miller; Nilla Majahalme; Cynthia Hau; Lauren MacMullen; Sanjay Advani; Sophie A Ludin; Andrew J Zimolzak; Jason L Vassy
Journal:  Clin Transl Sci       Date:  2019-12-18       Impact factor: 4.689

8.  How pragmatic are the randomised trials used in recommendations for control of glycosylated haemoglobin levels in type 2 diabetic patients in general practice: an application of the PRECIS II tool.

Authors:  Isabelle Ettori-Ajasse; Elise Tatin; Gordon Forbes; Sandra Eldridge; Clarisse Dibao-Dina
Journal:  Trials       Date:  2020-03-19       Impact factor: 2.279

9.  Improving the relevance of randomised trials to primary care: a qualitative study investigating views towards pragmatic trials and the PRECIS-2 tool.

Authors:  Gordon Forbes; Kirsty Loudon; Megan Clinch; Stephanie J C Taylor; Shaun Treweek; Sandra Eldridge
Journal:  Trials       Date:  2019-12-11       Impact factor: 2.279

Review 10.  Design characteristics of comparative effectiveness trials for the relief of symptomatic dyspepsia: A systematic review.

Authors:  Natalie Elliott; Amie Steel; Bradley Leech; Wenbo Peng
Journal:  Integr Med Res       Date:  2020-09-22
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.